Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals-Reference-Cited by-同舟云学术

Oral, ultra–long-lasting drug delivery: Application toward malaria elimination goals

Published:2016-11-16 Issue:365 Volume:8 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Bellinger Andrew M.¹²³,Jafari Mousa¹,Grant Tyler M.¹³,Zhang Shiyi¹,Slater Hannah C.⁴,Wenger Edward A.⁵,Mo Stacy¹,Lee Young-Ah Lucy¹,Mazdiyasni Hormoz¹,Kogan Lawrence¹,Barman Ross¹,Cleveland Cody¹⁶,Booth Lucas¹,Bensel Taylor¹,Minahan Daniel¹,Hurowitz Haley M.¹,Tai Tammy¹,Daily Johanna⁷,Nikolic Boris⁸,Wood Lowell⁵,Eckhoff Philip A.⁵,Langer Robert¹⁹¹⁰,Traverso Giovanni¹⁶¹¹

Affiliation:

1. Department of Chemical Engineering and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

2. Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.

3. Lyndra Inc., Watertown, MA 02472, USA.

4. Department of Infectious Disease Epidemiology, MRC (Medical Research Council) Centre for Outbreak Analysis and Modelling, Imperial College London, London, U.K.

5. Institute for Disease Modeling, Bellevue, WA 98005, USA.

6. Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.

7. Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

8. Biomatics Capital, 1107 1st Avenue, Apartment 1305, Seattle, WA 98101, USA.

9. Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

10. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

11. Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Abstract

A newly developed platform capable of oral, ultra–long-acting drug delivery could be applied against the malaria vector in elimination programs.

Funder

Alexander von Humboldt-Stiftung Foundation

NIH

National Sciences and Engineering Research Council of Canada

Bill and Melinda Gates Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference48 articles.

1. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention

2. Case studies in swelling polymeric gastric retentive tablets

3. Baclofen novel gastroretentive extended release gellan gum superporous hydrogel hybrid system: in vitro and in vivo evaluation

4. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral administration microrobots for drug delivery;Bioactive Materials;2024-09

2. An ingestible, battery-free, tissue-adhering robotic interface for non-invasive and chronic electrostimulation of the gut;Nature Communications;2024-08-08

3. The Advances in Phospholipids-Based Phase Separation Gels for the Sustained Release of Peptides, Proteins, and Chemotherapeutics;Pharmaceutics;2024-06-29

4. Advanced material technologies for space and terrestrial medicine;Nature Reviews Materials;2024-06-03

5. 3D printing of multi-unit gastro-retentive tablets for the pulsatile release of artesunate;International Journal of Pharmaceutics;2024-06